These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20045649)

  • 1. Synthesis and structural and pharmacological properties of cyclopropane-based conformationally restricted analogs of 4-methylhistamine as histamine H3/H4 receptor ligands.
    Kobayashi T; Watanabe M; Yoshida A; Yamada S; Ito M; Abe H; Ito Y; Arisawa M; Shuto S
    Bioorg Med Chem; 2010 Feb; 18(3):1076-82. PubMed ID: 20045649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
    Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
    J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of histamine H
    Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
    Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
    Tedford CE; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Handley MK; Yates SL
    J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity.
    Wijtmans M; de Graaf C; de Kloe G; Istyastono EP; Smit J; Lim H; Boonnak R; Nijmeijer S; Smits RA; Jongejan A; Zuiderveld O; de Esch IJ; Leurs R
    J Med Chem; 2011 Mar; 54(6):1693-703. PubMed ID: 21348462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
    Lee-Dutra A; Arienti KL; Buzard DJ; Hack MD; Khatuya H; Desai PJ; Nguyen S; Thurmond RL; Karlsson L; Edwards JP; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6043-8. PubMed ID: 16990005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.
    Ishikawa M; Shinei R; Yokoyama F; Yamauchi M; Oyama M; Okuma K; Nagayama T; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 May; 53(9):3840-4. PubMed ID: 20384344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors.
    Cricco GP; Mohamad NA; Sambuco LA; Genre F; Croci M; Gutiérrez AS; Medina VA; Bergoc RM; Rivera ES; Martín GA
    Inflamm Res; 2008; 57 Suppl 1():S23-4. PubMed ID: 18345506
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: cyclopropane-based conformationally restricted analogs of haloperidol.
    Yamaguchi K; Kazuta Y; Hirano K; Yamada S; Matsuda A; Shuto S
    Bioorg Med Chem; 2008 Oct; 16(19):8875-81. PubMed ID: 18793859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
    Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
    Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.